STEMI with multivessel disease: An ongoing battle for the optimal treatment strategy

被引：0
|
作者：
Farhan, Serdar [1 ]
Mehran, Roxana [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Zena & Michael Wiener Cardiovasc Inst, New York, NY 10029 USA
来源：
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS | 2016年 / 88卷 / 05期
关键词：
PERCUTANEOUS CORONARY INTERVENTION; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL;
D O I：
10.1002/ccd.26823
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Key Points Multivessel compared to single vessel PCI in patients with STEMI is associated with younger age and less comorbid conditions Multivessel PCI for patients with STEMI and multivessel disease appears to be safe without increased mortality compared to infarct-related artery only PCI. Results from ongoing large-scale randomized trials are under way to provide robust evidence of the ideal interventional therapy of patients with STEMI and multivessel disease.
引用
收藏
页码：707 / 708
页数：2
相关论文
共 50 条
  • [21] Hybrid Strategy for Stent Treatment for Multivessel Coronary Artery Disease
    Romero, Miguel
    Medina, Alfonso
    Suarez de Lezo, Jose
    Pan, Manuel
    Suarez de Lezo, Javier, Jr.
    Segura, Jose
    Martin, Pedro
    Ojeda, Soledad
    Pavlovic, Djordje
    Amador, Celestina
    Mazuelos, Francisco
    Crespin, Manuel
    Garcia, Daniel
    [J]. CIRCULATION, 2009, 120 (18) : S973 - S973
  • [22] Optimal Medical Treatment: Is It the Worst Option in Multivessel Coronary Disease?
    Morales Salinas, Alberto
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2014, 67 (12): : 1074 - 1074
  • [23] Heart disease - An ongoing genetic battle?
    Srivastava, D
    [J]. NATURE, 2004, 429 (6994) : 819 - +
  • [24] STEMI in a Patient with Multivessel Disease: Culprit-lesion Only or Multivessel Primary PCI?
    Lu, Hou Tee
    Ang, Kai Ping
    Lee, Chuey Yan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (16) : S93 - S94
  • [25] Optimal reperfusion strategy in patients with acute STEMI and multivessel disease—an updated meta-analysis; [Optimale Reperfusionsstrategie bei Patienten mit akutem STEMI und Mehrgefäßerkrankung – aktualisierte Metaanalyse]
    Fan G.
    Zhang Y.W.
    Lin L.
    Chen M.
    Wei J.
    Diao J.
    [J]. Herz, 2020, 45 (3) : 272 - 279
  • [26] Optimal invasive strategy for multivessel coronary artery disease in elderly diabetic patients
    Kawecki, Damian
    Morawiec, Beata
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (11) : 1871 - 1872
  • [27] CHANGES IN MANAGEMENT OF STEMI WITH MULTIVESSEL DISEASE IN A CARDIAC CATHETERIZATION LAB
    Halevy, J. B.
    Gogo, P. B.
    [J]. CARDIOLOGY, 2016, 134 : 75 - 75
  • [28] Is Optimal Medical Therapy "Optimal Therapy" for Multivessel Coronary Artery Disease? Optimal Management of Multivessel Coronary Artery Disease
    Williams, David O.
    Vasaiwala, Samip C.
    Boden, William E.
    [J]. CIRCULATION, 2010, 122 (10) : 943 - 945
  • [29] The optimal treatment strategy for secondary mitral regurgitation: a subject of ongoing debate
    Petrus, Annelieke H. J.
    Klautz, Robert J. M.
    De Bonis, Michele
    Langer, Frank
    Schaefers, Hans-Joachim
    Wakasa, Satoru
    Vahanian, Alec
    Obadia, Jean-Francois
    Assi, Roland
    Acker, Michael
    Siepe, Matthias
    Braun, Jerry
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2019, 56 (04) : 631 - 642
  • [30] Culprit or Multivessel Treatment for STEMI: The Opinion of a Repented Principal Investigator
    Di Mario, Carlo
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2011, 77 (02) : 171 - 173
12345